BOULDER, Colo., Feb. 26, 2013 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Cowen Annual Health Care Conference in Boston. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.
Cowen Annual Health Care Conference
Ron Squarer, Chief Executive Officer
Tuesday, March 5, 2013
8:00 a.m. Eastern Time
Marriott Copley Place Hotel, Boston, Mass.
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. During 2013, Array expects to make substantial progress in generating data to inform registration study decisions for our wholly-owned hematology programs, ARRY-520 and ARRY-614. Array-invented MEK162 will be tested in a Phase 3 trial in NRAS melanoma which is scheduled to start in April 2013, as well as BRAF mutant melanoma later in 2013 (with Novartis). Also, AstraZeneca recently announced a potential start of a Phase 3 trial with Array-invented selumetinib in non-small cell lung cancer during the second half of 2013. For more information on Array, please go to www.arraybiopharma.com.
Array BioPharma Inc.
SOURCE Array BioPharma Inc.